Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

China Regenerative Medicine International Ltd

+ Add to Watchlist

8158:HK

0.330 HKD 0.0000.00%

As of 03:20:41 ET on 03/27/2015.

Snapshot for China Regenerative Medicine International Ltd (8158)

Open: 0.335 Day's Range: 0.325 - 0.335 Volume: 31,295,000
Previous Close: 0.330 52wk Range: 0.215 - 0.360 1-Yr Rtn: +15.79%

Stock Chart for 8158

No chart data available.
  • 8158:HK 0.330
  • 1D
  • 1M
  • 1Y
0.330
Interactive 8158 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8158

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. HSI -
Earnings Per Share (ttm) -0.0259
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 5,096.31
Shares Outstanding (M) 15,212.88
30 Day Average Volume 40,304,950
Price/Book (mrq) 5.2384
Price/Sale (ttm) 1,758.3641
Dividend Indicated Gross Yield -%
Cash Dividend (HKD) -
Dividend Ex-Date 07/10/2003
5 Year Dividend Growth -
Next Earnings Announcement 07/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8158

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 8158

China Regenerative Medicine International Limited is engaged in research and development of bio-medical and healthcare products, and medical techniques, the provision of the production and sales of tissue engineering products and its related by-products, as well as sales and distribution of medical products and equipment.

Shao ZhengkangChief Executive OfficerWang YurongExecutive Director
Chan YimSecretaryDai YuminCompliance Officer
More Company Profile & Key Executives for 8158

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil